Copyright © 2024 · MediLumine, Inc · All Rights Reserved
Analytical and
In Vivo Imaging
Services
Maximize the value of your in vivo research with small animal biodistribution,
neuroscience and Oncology Studies
Take your Preclinical Discovery Research to New Frontiers
Our tested framework across various imaging modalities (MRI, PET, CT, Optical Bioluminescence, SWIR) and quality assurance policies have been used by hundreds of scientists to get answers to their preclinical discovery questions. As experts in preclinical research, MediLumine offers in animal in vivo CRO services to help with various goals such as assessing effectiveness of an oncology therapeutic, measuring kinetics of drug diffusion through blood brain barrier or quantify biodistribution.
Services Provided
In Vivo Imaging Services
Analytical Services
Methodology Consultation
Post-Processing Pipeline Support
In Vivo Imaging Services
State-of-the-art in vivo imaging solutions, offering a comprehensive range of modalities tailored to preclinical research and drug development. Whether you’re investigating disease progression, therapeutic efficacy, or molecular imaging, our multimodal imaging services provide unmatched resolution, sensitivity, and quantitative analysis to advance your research.
- Magnetic Resonance Imaging (MRI) – High-resolution anatomical and functional imaging for brain, tumor, and organ studies.
- In Vivo Optical Imaging – Monitoring cellular and molecular events with bioluminescence or fluorescence imaging.
- Positron Emission Tomograph (PET-CT) – Quantitative, high-sensitivity imaging for metabolic and tracer-based studies.
- Single Photon Emission Computed Tomography (SPECT-CT) – high-resolution functional and anatomical data to support drug development.
- DEXA (Dual-Energy X-ray Absorptiometry) for bone mineral density (BMD), body composition, and lean/fat mass distribution in small animal.
- Short-Wave Infrared (SWIR) Imaging – Deep tissue penetration and enhanced contrast for real time drug biodistribution.
- Mesoscopic Calcium Imaging – Functional connectivity studies and imaging cortex wide neuronal signaling with genetically encoded calcium indicators.
Analytical Services
analytical services to support drug discovery, contrast agent development, and biomolecular research. Using advanced NMR, HPLC, and LC-MS technologies, we provide precise characterization, quantification, and quality control of small molecules, contrast agents, and biologics.
- LC-MS & HPLC – Drug quantification, purity analysis, and metabolic profiling
- NMR & Mass Spectrometry – Structural elucidation and compound identification
- HPLC Pharmacokinetic (PK) profiling of drug formulations
- NMR Purity assessment of synthesized compounds
- LC-MS metabolic profiling and biodistribution studies
Methodology Consultation
As trusted consultants in imaging methods, we provide focused feedback pertaining to:
- Standardizing quantification methods for imaging data
- Enhancement of acquisition parameters for streamlining post-processing and analysis
- Optimization of imaging workflows for increased efficiency and throughput
Post-Processing Pipeline Support
MediLumine offers the establishment of post-processing pipelines for the efficient use of data. This includes:
- Providing Secure Depositories for HIPPA-Compliant Remote Data Sharing
- Providing Software for Accelerated Image Analysis and Quantitation
- Providing Reporting Tools for Data Presentation that Lead to Significant Interpretations
Our tested framework across various imaging modalities (MRI, PET, SPECT, CT, Optical Bioluminescence, SWIR, DEXA) and quality assurance policies have been used by hundreds of scientists to get answers to their preclinical discovery questions. As experts in preclinical research, MediLumine offers various in animal in vivo CRO services to help with various goals such as assessing effectiveness of an oncology therapeutic, measuring kinetics of drug diffusion through blood brain barrier or quantify biodistribution.
Benefits of Working with MediLumine
Schedule a call with our application scientists so that we can determine the best route (analytical, imaging or both) to get you the most significant quantitative results and answers to your questions related to your preclinical discovery research.
We guarantee the employment of systemic methodologies geared towards objective analysis of diverse datasets, allowing you to draw data-driven interpretations.